Adamska, Aleksandra
Chahin, Hanna
Muciño-Olmos, Erick Andrés
Esfandyari, Javanshir
Aaltonen, Kristina
Granados-Aparici, Sofia
Siaw, Joachim Tetteh
Radke, Katarzyna
Lago, Chiara
Pasikowski, Paweł
Pluta, Roman
Sawicka, Anna
Glaza, Przemysław
Gisselsson, David
Navarro, Samuel
Noguera, Rosa
Majkut, Joanna
Dobrzański, Paweł
Cottens, Sylvain
Walczak, Michał J.
Bexell, Daniel
Funding for this research was provided by:
Lund University
Article History
Received: 11 August 2025
Accepted: 13 January 2026
First Online: 6 February 2026
Declarations
:
: All in vivo procedures were conducted according to the guidelines from the Swedish Ethics Committee for Animal Research (permit nr 19012-19 and 15579-24).
: Not applicable.
: Authors affiliated with Captor Therapeutics (P.P., R.P., A.S., P.G., J.M., P.D., S.C., M.J.W.) are employees of the company, receive financial compensation, and hold shares in the company. A.A. is a former employee of Captor Therapeutics and is a stockholder. D.B. has received research project funding from Captor Therapeutics. The remaining authors declare that they have no competing interests.